[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application

NCT05458544 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: [177Lu]Ludotadipep 3.7 GBq

Sponsor

FutureChem